Aetna Company Profile (NYSE:AET)

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web:
  • Market Cap: $51.77174 billion
  • Outstanding Shares: 331,700,000
Average Prices:
  • 50 Day Moving Avg: $152.15
  • 200 Day Moving Avg: $136.01
  • 52 Week Range: $104.59 - $157.55
  • Trailing P/E Ratio: 47.65
  • Foreward P/E Ratio: 15.72
  • P/E Growth: 1.40
Sales & Book Value:
  • Annual Revenue: $62.63 billion
  • Price / Sales: 0.83
  • Book Value: $42.99 per share
  • Price / Book: 3.63
  • Annual Dividend: $2.00
  • Dividend Yield: 1.3%
  • EBIDTA: $5.73 billion
  • Net Margins: 1.84%
  • Return on Equity: 17.75%
  • Return on Assets: 4.53%
  • Debt-to-Equity Ratio: 0.57%
  • Current Ratio: 0.47%
  • Quick Ratio: 0.47%
  • Average Volume: 2.18 million shs.
  • Beta: 0.54
  • Short Ratio: 3.37
Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Friday, May 19th. Shareholders of record on Thursday, July 13th will be given a dividend of $0.50 per share on Friday, July 28th. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date is Tuesday, July 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna announced that its board has initiated a share buyback program on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 98% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) posted its quarterly earnings data on Tuesday, May, 2nd. The company reported $2.71 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.36 by $0.35. The firm had revenue of $15.17 billion for the quarter, compared to the consensus estimate of $15.39 billion. Aetna had a return on equity of 17.75% and a net margin of 1.84%. The business's quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.30 earnings per share. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Thursday, August, 3rd 2017. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna updated its FY17 earnings guidance on Friday, May, 19th. The company provided earnings per share guidance of $8.80 to $9.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.97.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

20 analysts have issued 12-month price objectives for Aetna's stock. Their predictions range from $128.00 to $180.00. On average, they anticipate Aetna's share price to reach $153.24 in the next twelve months. View Analyst Ratings for Aetna.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna expects long-term growth from its Government business. Cost-reduction initiatives, growing ACO collaborations pave the way for long-term growth. A strong balance sheet is another positive. Following a strong first quarter results, Aetna increased its earnings guidance. Year to date, the stock of Aetna has outperformed the Zacks categorized Medical Health Maintenance Organization industry. The stock has also witnessed an upward revision in earning estimates over the past 60 days. However, Aetna’s merger with Humana, which would have raised its rank in the industry, has been called off. Aetna has also been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (7/4/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
  • 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
  • Karen S. Lynch, President
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
  • Francis S. Soistman Jr., Executive Vice President - Government Services
  • Edward J. Ludwig, Lead Independent Director
  • Fernando G. Aguirre, Independent Director

Who owns Aetna stock?

Aetna's stock is owned by a variety of of retail and institutional investors. Top institutional investors include APG Asset Management N.V. (0.32%), NN Investment Partners Holdings N.V. (0.23%), PGGM Investments (0.21%), Focused Investors LLC (0.21%), Bank of Montreal Can (0.13%) and Strs Ohio (0.12%). Company insiders that own Aetna stock include Francis S Soistman Jr, Franklin Barbara Hackman, Gary W Loveman, Jeffrey E Garten, Joseph M Zubretsky, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Handelsbanken Fonder AB, Focused Investors LLC, APG Asset Management N.V., James Investment Research Inc., PGGM Investments, Sit Investment Associates Inc. and Russell Investments Group Ltd.. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Jeffrey E Garten, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Atalanta Sosnoff Capital LLC, Strs Ohio, NN Investment Partners Holdings N.V., Mn Services Vermogensbeheer B.V., ING Groep NV, DnB Asset Management AS and National Pension Service. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $156.25.

MarketBeat Community Rating for Aetna (NYSE AET)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  614 (Vote Outperform)
Underperform Votes:  361 (Vote Underperform)
Total Votes:  975
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $153.24 (1.93% downside)

Analysts' Ratings History for Aetna (NYSE:AET)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/13/2017Deutsche Bank AGBoost Price TargetHold$144.00 -> $157.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 -> $165.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$180.00LowView Rating Details
6/9/2017Royal Bank Of CanadaBoost Price TargetOutperform$147.00 -> $162.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageOverweight -> Overweight$162.00MediumView Rating Details
5/30/2017ArgusReiterated RatingBuy$145.00 -> $165.00LowView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/12/2017Cantor FitzgeraldReiterated RatingBuy$150.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
5/3/2017Jefferies Group LLCReiterated RatingHold$133.00 -> $140.00LowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/3/2016BMO Capital MarketsBoost Price TargetOutperform$128.00 -> $129.00N/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00N/AView Rating Details
8/4/2015Susquehanna Bancshares IncReiterated RatingBuy$135.00N/AView Rating Details
(Data available from 7/26/2015 forward)


Earnings History for Aetna (NYSE:AET)
Earnings by Quarter for Aetna (NYSE:AET)
Earnings History by Quarter for Aetna (NYSE AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017$2.34N/AView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.65
2018 EPS Consensus Estimate: $9.77
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.23$2.42$2.29
Q4 20174$1.63$1.74$1.68
Q1 20181$2.70$2.70$2.70
Q2 20181$2.64$2.64$2.64
Q3 20181$2.55$2.55$2.55
Q4 20181$1.88$1.88$1.88
(Data provided by Zacks Investment Research)


Current Dividend Information for Aetna (NYSE:AET)
Next Dividend:7/28/2017
Annual Dividend:$2.00
Dividend Yield:1.28%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:62.31% (Trailing 12 Months of Earnings)
22.25% (Based on This Year's Estimates)
20.12% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 91.80%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
DateHeadline logoThe Boss Wants You Back in the Office - July 26 at 1:30 AM logo[$$] The Boss Wants You Back in the Office - July 25 at 3:24 PM logoStrong Obamacare business boosts Centene's quarterly results - July 25 at 3:24 PM logoAetna Inc. (AET) Receives Average Rating of "Buy" from Analysts - July 25 at 12:51 AM logoHealthcare Stocks Mixed Following President Trump's Comments on Senate Bill - July 24 at 6:45 PM logoWellCare Health Plans (WCG) versus Aetna (NYSE:AET) Financial Analysis - July 24 at 10:04 AM logoAetna Inc. (AET) Downgraded by BidaskClub - July 23 at 8:08 PM logoAetna CEO Bertolini: The future is about the people behind me - July 23 at 3:24 PM logoAetna CEO Bertolini: How tech plays into the future of healthcare - July 23 at 3:24 PM logoAetna CEO Bertolini: How his own accident and son’s cancer changed his journey - July 23 at 3:24 PM logoAetna CEO Bertolini: Why he pays his employees to sleep - July 23 at 3:24 PM logoAETNA CEO: Obamacare can't be repealed but it can be fixed - July 21 at 4:51 PM logoAetna CEO: Here's why health care in the U.S. is so expensive - July 21 at 4:51 PM logoOvernight GOP healthcare meeting - Seeking Alpha - July 20 at 10:01 PM logoAetna to Announce Second-Quarter 2017 Results - July 20 at 10:01 PM logoIYH, DHR, AET, ANTM: Large Outflows Detected at ETF - July 20 at 4:02 PM logoHealth care bill dead, Trump reacts - July 20 at 4:02 PM logoThe future of American healthcare is in limbo - July 20 at 4:02 PM logoTrump can’t ‘let’ Obamacare fail — but he can help destroy it - July 20 at 4:02 PM logoGOP mulling working with Dems on healthcare plan - Seeking Alpha - July 19 at 4:10 PM logoHealth Carrier Stocks Need to Hold These Levels - July 19 at 4:10 PM logoUnitedHealth Beats Profit Estimates After Obamacare Exit - New York Times - July 18 at 9:15 PM logoGOP abandons healthcare bill - Seeking Alpha - July 18 at 9:15 PM logoRepublican push to end Obamacare collapses in U.S. Senate - July 18 at 9:15 PM logoUnitedHealth beats profit estimates after Obamacare exit - July 18 at 4:14 PM logoUnitedHealth 2Q profit surges as ACA participation shrinks - July 18 at 4:14 PM logoAetna Inc. (AET) Expected to Announce Quarterly Sales of $15.30 Billion - July 15 at 8:15 AM logoDifficult path ahead for healthcare bill - Seeking Alpha - July 14 at 5:21 PM logoBank of America Corporation Boosts Aetna Inc. (NYSE:AET) Price Target to $18.00 - July 14 at 4:18 PM logoAetna CEO Says GOP Health Bill Needs to Be Fixed - July 13 at 9:18 PM logoAetna Inc. (NYSE:AET) PT Raised to $157.00 at Deutsche Bank AG - July 13 at 7:14 PM logo Brokerages Anticipate Aetna Inc. (NYSE:AET) to Announce $2.34 EPS - July 13 at 4:33 PM logoSorry Trump—Obamacare is alive and well - July 13 at 4:17 PM featured highlights: Guess', Aetna, Tivity Health, Logitech International and ARI Network Services - July 13 at 4:17 PM logoCigna (CI) Hits 52-Week High on Recent Buyout, Growth Plans - July 13 at 4:17 PM logoAetna's (AET) Outperform Rating Reaffirmed at Credit Suisse Group - July 13 at 8:13 AM logoNarus Financial Partners, LLC Buys Phillips 66, NVIDIA Corp, Aetna Inc, Sells Cardtronics PLC, ... - Nasdaq - July 12 at 3:53 PM logoHealthcare battle goes into overtime - Seeking Alpha - July 12 at 3:53 PM logoAetna Adds Behavior-Based Security to Customer Application - Wall Street Journal (subscription) (blog) - July 12 at 3:53 PM logoAetna Adds Behavior-Based Security to Customer Application - July 12 at 3:53 PM logoStock Traders Purchase High Volume of Aetna Call Options (AET) - July 10 at 6:08 PM logoAetna Inc. (AET) Ex-Dividend Date Scheduled for July 11, 2017 - Nasdaq - July 10 at 3:32 PM logoEx-Div Reminder for Aetna - July 7 at 5:12 PM logoDividend Coverage: Aetna has a Dividend Yield of 1.30%; Will Trade Ex-Dividend on July 11, 2017 - July 7 at 5:12 PM logoAetna warns it may terminate Medicaid contracts in Illinois - July 6 at 9:56 PM logoWhy the Earnings Streak Will Continue for Aetna (AET) - July 6 at 4:55 PM logoLifePoint (LPNT) Thriving on Inorganic Growth, Ample Capital - July 5 at 3:58 PM logoAetna's move to Manhattan spotlights challenges in Connecticut - July 5 at 3:58 PM logoZacks Investment Research Upgrades Aetna Inc. (NYSE:AET) to "Buy" - July 4 at 4:04 PM logoAetna to Shift Headquarters, Aims Business Transformation - July 3 at 3:30 PM



Aetna (AET) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by Staff